Author Manuscript
HHS Public Access

Estradiol induces dendritic spines by enhancing glutamate release independent of transcription: A mechanism for organizational sex differences

Jaclyn M. Schwarz, Shu-Ling Liang, [...], and Margaret M. McCarthy

Additional article information

SUMMARY

The naturally occurring sex difference in dendritic spine number on hypothalamic neurons offers a unique opportunity to investigate mechanisms establishing synaptic patterning during perinatal sensitive periods. A major advantage of the model is the ability to treat neonatal females with estradiol to permanently induce the male phenotype. During the development of other systems, exuberant innervation is followed by activity-dependent pruning necessary for elimination of spurious synapses. In contrast, we demonstrate that estradiol-induced organization in the hypothalamus involves the induction of new synapses on dendritic spines. Activation of estrogen receptors by estradiol triggers a non-genomic activation of PI3 kinase that results in enhanced glutamate release from presynaptic neurons. Subsequent activation of ionotropic glutamate receptors activates MAP kinases inducing dendritic spine formation. These results reveal a trans-neuronal mechanism by which estradiol acts during a sensitive period to establish a profound and lasting sex difference in hypothalamic synaptic patterning.

INTRODUCTION

Determining the mechanisms underlying the formation of functional neuronal circuits is central to understanding brain development. Variation in neuronal activity, hormonal milieu, or environmental cues can permanently change the formation of specific circuits and the phenotype of individual neurons during a developmental sensitive period. This concept is well established in the visual cortex (Desai et al., 2002; Wong, 1999; Zhang and Poo, 2001), motor neuron circuits (Hanson and Landmesser, 2004; Haverkamp and Oppenheim, 1986), and the song control circuit in birds (Iyengar and Bottjer, 2002), in which, respectively, light, movement or sound affect spontaneous activity in the neurons and in so doing establish the proper synaptic connections for optimal function. Appropriate synaptic connections must also be achieved in male and female brains where fundamental neuronal differences mediate the well-known sex differences in physiology and behavior. In rodents, these sex differences are determined during a critical period of development by estradiol, which is aromatized from testicular androgens in the male (Naftolin et al., 1971). Early estradiol exposure permanently differentiates the male from the female rodent brain by establishing sex differences in synaptic connections and neuronal morphology to affect behavior (De Vries and Simerly, 2002; McCarthy, 2008).

Dendritic spines are anatomical loci of excitatory synapses on neurons. Spine formation and maintenance are sensitive to both electrical and chemical stimulation. Estradiol is an important regulator of dendritic spines in many brain regions during development (Amateau and McCarthy, 2002b; Matsumoto and Arai, 1980, 1986b; Pozzo Miller and Aoki, 1991; Todd et al., 2005) and adulthood (Calizo and Flanagan-Cato, 2000; Carrer and Aoki, 1982; Murphy and Segal, 1996; Woolley and McEwen, 1992), thereby influencing behavior and reproductive function. In newborn rats, males have twice the number of dendritic spines on hypothalamic neurons as females and treatment of females at birth with testosterone, which is centrally aromatized to estradiol in the brain, increases the number of dendritic spines to that of males (Todd et al., 2007). However, the mechanism(s) by which estradiol permanently organizes a sex difference in dendritic spines in the MBH remain unknown.

The classic model of estradiol action involves ligand binding to a nuclear receptor, dimerization and recruitment of co-activators, followed by initiation of gene transcription at estrogen response elements (ERE) found in the promoter region of estrogen-responsive genes. Estrogen receptors (ER) are members of a super-family of nuclear transcription factors that regulate gene expression (Beato, 1989; Uht et al., 1997). Dense concentrations of ER are found in neonatal hypothalamic neurons of males and females (Shughrue et al., 1997; Simerly et al., 1990) and are directly linked to sexual differentiation of the brain (McCarthy et al., 1993; McEwen et al., 1977; Quadros et al., 2002). Activated estrogen receptors can also indirectly promote gene transcription independent of EREs via activation of kinases that in turn activate specific promoter elements. In the hypothalamus, ligand-bound ER activates protein kinase A, CREB (Abraham and Herbison, 2005; Aronica et al., 1994; Lee et al., 2004; Zhou et al., 1996), the mitogen-activated protein kinase (MAP kinase) MEK 1/2 (Singh et al., 1999), and phosphatidylinositol 3-kinase (PI3 kinase) (Znamensky et al., 2003). Thus estrogen receptor activation can be localized to the membrane, yet induce a host of effects which induce or facilitate transcriptional activity dependent or independent of the ERE (Vasudevan and Pfaff, 2007). To date, membrane-initiated effects of estradiol have not been reported in the developing brain, and in fact would seem unlikely given that rapid membrane effects are presumed not conducive to permanent organizational changes. We now report that estradiol promotes spine formation in the developing hypothalamus via rapid, non-genomic activation of PI3 kinase in presynaptic neurons, enhancing glutamate release and glutamate receptor activation in postsynaptic neurons. AMPA and NMDA receptor-dependent activation of postsynaptic MAP kinases then triggers a protein synthesis-dependent increase in dendritic spine number.

RESULTS

Estradiol and NMDA receptor activation increase dendritic spine number in the developing hypothalamus to establish a sex difference

On the day of birth, males had significantly more dendritic spines on Golgi-Cox impregnated hypothalamic neurons than females (main effect F3,19= 8.80, p = 0.0007, post-hoc p = 0.001; Fig 1a). Treatment of females with estradiol or NMDA for 6 hr significantly increased the number of spines compared to vehicle treated females (p = 0.001) and equivalent to levels seen on male neurons. Further analysis of the Golgi impregnated neurons revealed the increase in spine number was accompanied by an elongation of neuronal dendrites of 34% (F3,19=3.47, p = 0.036; Fig 1a). There was no difference in the density of dendritic spines (data not shown).

Figure 1
Estradiol and NMDA induce dendritic spines and spinophilin in the MBH

Newborn males also had significantly more spinophilin protein in the MBH than females, as determined by western blot analysis, confirming the previously reported correlation between increased dendritic spine number and increased spinophilin levels (Amateau and McCarthy, 2002a, 2004; Todd et al., 2005; Todd et al., 2007). Treatment of females with estradiol (250 μg) increased spinophilin to that of males within 6 hr (F2,15= 15.8; p = 0.002; Fig. 1b). To determine whether the effect of estradiol on dendritic spines at 6 hr was maintained at later time points, brains were also collected from animals 48 hr after a single injection of estradiol. Spinophilin levels remained significantly elevated 48 hr after estradiol treatment compared to control (F3,20= 4.09; p = 0.031, Fig 1c) and were not different from 6 hr of estradiol exposure (p = 0.901), confirming estradiol-induced dendritic spines are maintained for an extended period of time. The MBH is thus sexually dimorphic at birth with regard to spinophilin level and spine number, and the levels seen in males can be induced in females by treatment with estradiol or activation of the NMDA receptor.

Estradiol increases dendritic spines in the developing hypothalamus via activation of ionotropic glutamate receptors

We hypothesized that activation of glutamate receptors is necessary for the estradiol-induced increase in dendritic spines in the developing hypothalamus. We first treated animals with the AMPA-type glutamate receptor antagonist, NBQX (2.5 μg subcutaneously), prior to estradiol treatment. NBQX prevented the estradiol-induced increase in spinophilin (F3,17= 7.04; p = 0.002, Fig 2a). Treatment with NBQX alone had no effect. To determine if NMDA receptors are also required for estradiol-induced spinophilin, animals were pre-treated with the NMDA receptor antagonist, MK801 (10 μg subcutaneously), prior to estradiol treatment. MK801 completely blocked the estradiol-induced increase in spinophilin (F3,13= 13.29; p = 0.0003, Fig 2a). Treatment with MK801 alone had no effect on spinophilin levels.

Figure 2
Glutamate receptor activation is necessary and sufficient for estradiol-induced increases in dendritic spines

These results suggest that NMDA receptor activation is necessary for estradiol to induce dendritic spines. The ability of NMDA treatment in vivo to increase dendritic spines detected by Golgi impregnation suggested it is sufficient as well. We further confirmed this by treatment of female pups on the day of birth with estradiol, NMDA (10 μg s.c.), or vehicle. Direct activation of NMDA receptors mimicked the effect of estradiol by increasing spinophilin to the same degree over control females (F2,20=7.70; p = 0.002; Fig 2b). These data confirm the NMDA-mediated increase in dendritic spines seen using Golgi impregnation of VMN neurons (Fig 1a) and are consistent with previous reports indicating activation of AMPA receptors also increases dendritic spines in the developing female hypothalamus to the same degree as estradiol (Todd et al., 2007). We conclude that estradiol does not induce increases in spinophilin protein directly, but rather does so indirectly in a glutamate receptor-dependent manner. Furthermore, activation of glutamate receptors is not only necessary but also sufficient to induce sex differences in dendritic spine number in the developing hypothalamus.

Estradiol has no effect on the number or function of glutamate receptors in the developing hypothalamus

The pivotal observations from the previous experiments suggested activation of AMPA and NMDA receptors is required for estradiol-induced increases in dendritic spines. There are two potential mechanisms by which this could occur: 1) estradiol might alter the number or function of postsynaptic AMPA and/or NMDA receptors or 2) estradiol might act presynaptically to promote glutamate release directly from hypothalamic neurons.

To test the first hypothesis, male and female hypothalami were assessed by quantitative western blot for levels of the AMPA receptor subunits GluR1 and GluR2 and the requisite NMDA subunit, NR1. There was no sex difference and no effect of estradiol treatment on the amount of GluR1 (F2,18= 0.378; p = 0.690), GluR2 (F2,16= 0.488; p = 0.623) or NR1 (F2,14= 0.788; p = 0.474) in the neonatal MBH (Supplementary data Figure 1a).

In another experiment females were treated with or without estradiol (100 μg/0.1 ml sesame oil, sc) on PN0, 1 and 2; then AMPA-mediated miniature excitatory postsynaptic currents (mEPSCs) recorded from ventrolateral VMN (vlVMN) neurons on PN4−5, at which point estradiol-induced dendritic spines are fully established (Matsumoto and Arai, 1986a) (Fig 3b). We found no significant effect of estradiol on the median amplitude (t16=−0.87; p = 0.238), frequency (t16=−1.22; p = 0.396), or decay time (t16=−0.57; p = 0.572) of mEPSCs in the developing hypothalamus (n = 8 − 10 cells from vehicle or estradiol treated; Fig 3a). We conclude estradiol has no effect on the number of synaptic AMPA-type glutamate receptors in these neurons. We also found no effect on the computed ratio of synaptic AMPA-to-NMDA receptors, as seen by measuring the peak amplitude of EPSCs mediated by AMPA receptors and the amplitude of the NMDA receptor-mediated component of the EPSC (p = 0.8, n = 7 cells from each; (Fig 4a). Estradiol also had no effect on glutamate-induced calcium responses in cultured hypothalamic neurons as measured with the fluorescent ratiometric calcium-sensitive dye, fura-2. We found no difference in either the number of neurons that responded to glutamate (χ2= 1.65; p = 0.200) or the peak amplitude of the calcium response to glutamate (K-S test: χ2= 2.12; p = 0.697, Supplementary data Figure 1b).

Figure 3
Estradiol has no effect on mEPSC amplitude
Figure 4
Estradiol enhances glutamate release from hypothalamic neurons

Recorded neurons were filled with biocytin from the patch pipette and their morphology analyzed. Consistent with the morphological analysis of Golgi impregnated neurons (Fig 1a), neurons treated with estradiol had more dendritic spines along the primary dendrite compared to control (t7=2.67; p = 0.031) and the overall length of the dendrite was greater (t7=2.41; p = 0.060; Fig 3b). There was no effect of estradiol on the number of branches per dendrite or the dendritic spine density (data not shown).

Estradiol enhances presynaptic neurotransmitter release from glutamatergic terminals of developing hypothalamic neurons

Concluding that estradiol does not affect glutamatergic transmission postsynaptically, we hypothesized that estradiol promotes presynaptic glutamate release to increase dendritic spines. To test this hypothesis, we measured whole-cell voltage-clamp recordings to compare the paired-pulse ratio (PPR) in brain slices from female pups treated with or without estradiol treatment for up to 6 hr on PN2. The PPR is inversely correlated with release probability (Zucker and Regehr, 2002). The amplitude of the AMPA receptor-mediated EPSC elicited in response to the second of two stimuli delivered at an interstimulus interval of 50 ms was considerably facilitated compared to the first EPSC in cells in vehicle-treated slices (PPR = 1.85 ± 0.21, n = 11). In cells from estradiol treated slices, the amplitude of the second EPSC was also facilitated, but to a significantly smaller extent (PPR = 1.22 ± 0.09, n = 12) (t21=−2.72; p = 0.0127, Fig 4a). The decrease in the PPR in the estradiol treated slices is consistent with an estradiol-induced increase in the probability of release at glutamatergic synapses.

We next used the fluorescent styryl dye FM4−64 to assay the effects of estradiol on release probability more directly. Presynaptic boutons were labeled with FM4−64 and the probability of transmitter release was assayed by the rate of FM4−64 destaining in response to either KCl-induced depolarization or electrical field stimulation (Brager et al., 2003; Pyle et al., 1999; Ryan et al., 1996) (Supplementary data Fig 2). Post-hoc analysis of hypothalamic neurons revealed 100% co-localization of FM4−64 staining and VGLUT2 immunostaining, indicating the terminals analyzed for transmitter release were glutamatergic (vehicle: n=32 boutons; estradiol n=36 boutons from 2 separate cultures; Fig. 5a).

Figure 5
Estradiol enhances glutamate release within 3 hours

Treatment of hypothalamic neurons with estradiol for only 3 hr significantly increased the total fluorescence lost after 30 sec of depolarization with either 50 mM KCl or stimulation at 1 Hz via an electrode positioned near the imaged region, compared to untreated cultures (F3,16= 3.94, p = 0.027; Fig. 5b). After 120 seconds of depolarization, the total fluorescence lost for all groups was not significantly different (p = 0.223), indicating that the size of the recycling vesicle pool was not affected by estradiol.

Treatment with the estrogen receptor antagonist ICI 182,780 alone had no effect on the rate of destaining (p = 0.239; Fig 5c) but completely prevented estradiol-induced enhancement of FM4−64 destaining (F3,7=6.29, p = 0.032), indicating that estradiol enhanced glutamate release requires activation of the estrogen receptor.

There was no effect of estradiol treatment on the density of FM4−64 labeled boutons (F3,25= 0.86; p = 0.470) or the area of these boutons (F3,25= 0.26; p = 0.850) compared to controls (Supplementary data Figure 3).

When analyzed separately, neurons treated with estradiol for less than 2 hr showed an increase in neurotransmitter release when compared to vehicle treatment for the same amount of time (p = 0.05; Fig 5c inset), demonstrating that estradiol rapidly enhances the release of glutamate from developing hypothalamic neurons via activation of classical estrogen receptors. Notably, the increase in release probability within 2 hr precedes the increase in the number of dendritic spines, first detectable at 6 hr, and the activation of MAP kinase (see below) that are not detectable until 3 hr post-estradiol.

Estradiol-enhanced glutamate release does not require protein synthesis but does require activation of PI3 kinase

The rapid effect of estradiol on glutamate release from hypothalamic neurons suggested a non-genomic mechanism of action. Using 30μM cycloheximide to block RNA translation, we tested whether estradiol-enhanced neurotransmission required synthesis of new proteins. Blocking protein synthesis had no effect on estradiol-enhanced FM4−64 destaining in cultured hypothalamic neurons after 3 hr (F3,24= 3.66; p = 0.67; vehicle n = 8, E2 n = 8, CHX + E2 n = 8, CHX n = 4 coverslips), however, cycloheximide treatment did block the estradiol-induced increase in spinophilin protein (F3,18= 3.17; p = 0.0498; vehicle n = 6, E2 n = 6, CHX + E2 n = 6, CHX n = 4 coverslips Fig. 6a), confirming effective inhibition of protein synthesis and a requirement for protein synthesis in the promotion of spine formation. We conclude that estradiol can enhance neurotransmitter release by activating ER, however, the enhancement does not require the synthesis of new proteins.

Figure 6
Estradiol enhances neurotransmitter release via non-genomic activation of PI3 kinase

A time course analysis of phosphorylation of the PI3 kinase substrate Akt at ser473, using western blot, indicated that estradiol rapidly activated PI3 kinase within only 1 hr (F5,21=3.89,p = 0.048; Fig. 6b) and this activation was maintained at 3 hr and 6 hr after estradiol treatment (p = 0.038 and p = 0.0247 respectively; n = 4−5 coverslips for each group). The activation of PI3K by estradiol therefore just precedes the enhancement of glutamate release, which occurs at 2−3 hr after treatment, suggesting that it may underlie the increase in release probability. We tested this hypothesis by blocking PI3 kinase activation with the specific inhibitor LY294002 (10 μM) and found it completely prevented estradiol-enhanced neurotransmitter release (F3.22= 3.91; p = 0.023, vehicle, n = 7, E2 n = 7, LY + E2 n = 8, LY n = 4 coverslips Fig. 6b). If enhanced glutamate release via estradiol-induced activation of PI3K is necessary for increasing dendritic spine number, then blocking estradiol-enhanced glutamate release with LY294002 would also block the ability of estradiol to increase dendritic spines in these neurons. As predicted, application of LY294002 also blocked estradiol-induced formation of dendritic spines as determined by western blot for spinophilin (F3,15= 4.39; p = 0.003; n = 4−5 coverslips per group, Fig. 6b).

These pharmacological experiments, taken together with the time course of events, are consistent with a model in which estradiol acts via estrogen receptors to activate PI3K via a non-transcriptional mechanism, PI3K activation enhances presynaptic glutamate release, thereby increasing postsynaptic AMPA and NMDA receptor activation to induce spine formation.

Estradiol-induced glutamate release activates MAP kinase in the postsynaptic neuron to increase dendritic spines

We also determined that estradiol activates the MAP kinase, MEK 1/2, as seen by phosphorylation of its substrate ERK 1/2, just prior to the estradiol-induced increase in spinophilin (Fig 7a). By 3 hr post-estradiol treatment, there was significant activation of MEK 1/2 (F2,12=6.60, p = 0.042), that was not seen at 1 hr but maintained for up to 6 hr after estradiol (p = 0.002; Fig. 7c). This time course suggests activation of MAP kinase by estradiol occurs at a point after the enhanced release of glutamate, and that estradiol-induced activation of MAP kinase occurs downstream of glutamate receptor activation to induce dendritic spine formation. This led to the prediction that blocking MAP kinase would have no effect on estradiol-enhanced neurotransmitter release in hypothalamic neurons, and indeed blocking MAP kinase with PD98059 had no effect on estradiol-enhanced FM4−64 destaining (F3,22= 6.67; p = 0.169, vehicle n = 7, E2 n = 7, PD + E2 n= 8, PD n = 4 coverslips Fig. 7a).

Figure 7
Estradiol activates MAP kinase downstream of glutamate receptor activation to induce dendritic spine formation

Earlier experiments revealed that treatment of females with the glutamate receptor antagonists NBQX or MK801 completely blocked estradiol-induced increases in spinophilin (see Fig. 2). In the same animals, NBQX treatment also completely blocked the estradiol-induced activation of MAP kinase (F3,17= 2.96; p = 0.041, Fig 7b). We determined that treatment with MK801 also prevented activation of MAP kinase by estradiol in vivo (F3,17= 4.79; p = 0.013, Fig 7b). Neither NBQX nor MK801 treatment alone effected basal levels of MAP kinase. These data confirm that activation of MAP kinase occurs downstream of glutamate receptor activation in the developing hypothalamus.

To determine if MAP kinase activity was required for the effect of estradiol on dendritic spines, animals were pre-treated with PD98059 (200 ng ICV). Indeed, PD98059 blocked both the estradiol-induced activation of MAP kinase (F3,16= 7.91, p = 0.002, Fig 7c) and the increase in spinophilin protein within 6 hours (F3,16= 12.8, p = 0.002; Fig. 7c). PD98059 treatment alone had no effect on spinophilin, indicating MAP kinase activity is not required to maintain basal spinophilin levels in the MBH.

We also determined that estradiol promoted an increase in spinophilin protein in cultured hypothalamic neurons generated from E18 embryos and assayed on day in vitro 5 (Supplementary data Figure 4a). We used this in vitro model to test the role of other kinases in the estradiol-induced increase in spinophilin. We found that blocking MEK 1/2 or the c Jun kinase (JNK) significantly blocked the estradiol-induced phosphorylation of ERK 1/2 (F4,19=3.77 p = 0.013; Supplementary data Figure 4b) and increase in dendritic spines (F4,19=8.38; p = 0.005; Supplementary data Figure 4c). Blocking activation of p38 MAP kinase, also located in the hypothalamus, had no significant effect on estradiol-induced ERK 1/2 activation (p = 0.936) or levels of spinophilin (p = 0.074). In addition, blocking protein kinase A (p = 0.130), protein kinase C (p = 0.067) and Cam Kinase II (p = 0.430) had no significant effect on estradiol-induced spinophilin in the hypothalamic neurons (Supplementary data Figure 5). We conclude that activation of glutamate receptors at a time after which estradiol enhances glutamate release, is necessary for estradiol-induced activation of at least two MAP kinases, MEK 1/2 and JNK, and possibly more. Consequently, activation of multiple MAP kinases is a necessary component of estradiol-induced dendritic spines in the developing hypothalamus.

Enhancing neurotransmitter release with α-latrotoxin mimics the effect of estradiol treatment on spinophilin levels

If estradiol promotes dendritic spine formation by enhancing glutamate release from developing hypothalamic neurons, then direct enhancement of neurotransmitter release should mimic the effects of estradiol and increase spinophilin levels in MBH neurons. To test this prediction, we treated cultured hypothalamic neurons with estradiol (10 nM), as a positive control; the estrogen antagonist ICI 182,780 (1μm) with or without estradiol; or α-latrotoxin (3 pM). Latrotoxin is a secretagogue that at low concentrations stimulates neurotransmitter release by facilitating the presynaptic exocytotic machinery (Capogna et al., 1996). As seen previously, there was an overall effect of treatment on spinophilin levels in hypothalamic neurons (F4,20= 9.86; p = 0.001; Fig. 8a). Specifically, treatment of neurons with estradiol significantly increased spinophilin compared to controls (p = 0.001, n=5−6 coverslips). Pre-treatment with ICI 182,780 blocked the estradiol-induced increase in spinophilin (p = 0.007 compared to estradiol treated), but had no effect on basal spinophilin (p = 0.439). Stimulation of glutamate release with α-latrotoxin induced an increase in spinophilin similar to that observed in estradiol-treated cultures (p = 0.68), under conditions in which we demonstrated that estrogen receptors were fully blocked by ICI. With estrogen receptors fully blocked, α-latrotoxin increased spinophilin levels to those seen with estradiol treatment. This experiment provides positive evidence that enhanced glutamate release alone is sufficient to promote the formation of new dendritic spines in the developing hypothalamus, and rules out any possible permissive postsynaptic role for estrogen receptor activation in the induction of dendritic spines, suggesting a completely presynaptic mechanism of estrogen action. In a separate experiment, we also observed that combined α-latrotoxin and estradiol treatment induced an increase in spinophilin expression (F3,26=3.65 main effect) that was not different from the increase induced by either alone (p = 0.221 and p = 0.220; Fig 8b), suggesting that α-latrotoxin occludes the effect of estradiol on hypothalamic neurons. Therefore, enhancing neurotransmitter release is sufficient to increase dendritic spines on developing hypothalamic neurons.

Fig 8
Evoked neurotransmitter release increases spinophilin levels in hypothalamic neurons

DISCUSSION

A major role of steroids in the adult brain is modulation of neuronal plasticity, with an increasing emphasis on rapid but transient effects (Balthazart and Ball, 2006). In marked contrast, estradiol action in the developing brain permanently organizes the neural substrate, making a rapid membrane-initiated effect an unlikely mechanism by which this end would be achieved. To our surprise, we have found that the initial event in estradiol-mediated organization of dendritic spine synapses of the developing hypothalamus begins with a transcription-independent activation of PI3 kinase within 1 hr of steroid exposure, as demonstrated by an increase in the phosphorylation of its substrate, Akt. The activation of PI3 kinase was maintained for at least 6 hr under continuous estradiol exposure, as would be found in the developing brain.

Consequent to PI3 kinase activation we observed estradiol-enhanced glutamate release from hypothalamic neurons both in acutely prepared hypothalamic brain slices, as seen by a reduced paired-pulse ratio, and in primary cell cultures, as seen by examining the release of FM4−64 from presynaptic terminals. Application of a depolarizing stimulus, such as KCl or 1-Hz electrical stimulation, evoked calcium-dependent neurotransmitter release and destaining of FM4−64 from boutons that was significantly faster in neurons incubated with estradiol for only 2−3 hr prior to application of the depolarizing stimulus, compared to vehicle treated cultures. This action of estradiol on synaptic excitation was entirely presynaptic, as we detected no change in the number or function of postsynaptic glutamate receptors.

Estradiol-enhanced glutamate release required activation of PI3 kinase. Phosphoinositides are a key component of the membrane and their phosphorylation, by PI3 kinase, produces a signaling molecule important for the recruitment and phosphorylation of other proteins at the membrane (Cremona and De Camilli, 2001; Di Paolo and De Camilli, 2006; Toker and Cantley, 1997). As a result, they play an important role in the processes of exocytosis, endocytosis and trafficking of vesicles at the presynaptic membrane (Cousin et al., 2003; Lin et al., 2001; Opazo et al., 2003; Yokomaku et al., 2003). Though the exact mechanism of action remains unknown, phosphoinositides appear to act as a critical regulatory component of neurotransmitter release. We found that PI3 kinase inhibition did not block all neurotransmitter release, suggesting its role in estradiol-enhanced glutamate release may be to facilitate the fusion of synaptic vesicles to the target membrane (Rizzoli and Betz, 2002), either via changes in the dynamics of the membrane itself or phosphorylation of the proteins necessary for vesicle fusion (Cousin et al., 2003). PI3 kinase might also enhance glutamate release by facilitating the mobilization of calcium into the terminal (Gong et al., 2005; Holt et al., 2003; Mori et al., 2004). We conclude that the role of PI3 kinase in glutamate release appears specific, because inhibition of MAP kinase had no effect on estradiol-enhanced glutamate release; and blocking PKA, PKC and CamKII had no effect on estradiol-induced spinophilin. Moreover, there was no effect of the protein synthesis inhibitor, cycloheximide, on estradiol enhanced glutamate release, suggesting the activation of PI3 kinase by estradiol was due to a direct interaction between the two proteins, presumably in the presynaptic membrane.

The estradiol-enhanced glutamate release and glutamate receptor activation led to the activation of postsynaptic MAP kinases, as demonstrated by increased phosphorylation of ERK1/2. This effect was delayed compared to the activation of PI3 kinase, requiring at least 3 hr of estradiol exposure to become apparent, further confirming the temporal sequence of events. Blocking ionotropic glutamate receptors prevented activation of MAP kinase in response to estradiol and inhibition of the MAP kinases, MEK 1/2 and JNK, but not p38 Kinase, prevented the estradiol-mediated increase in spine number, leading to the conclusion that activation of multiple MAP kinases in the postsynaptic neuron is a consequence of enhanced glutamate receptor activation and not the result of a direct activation by the estrogen receptor. Inhibiting MAP kinase prevented the estradiol-induced increase in spinophilin, establishing a causal role of these enzymes in new spine construction in this system. Phosphorylation of ERK is implicated in the reorganization of actin filaments and thereby altering numerous cellular endpoints, including among many, the targeting of mRNA to dendritic spines (Huang et al., 2007), BK channel activation (O'Malley and Harvey, 2007), and AMPA receptor reorganization at the spine (Kim et al., 2005; Rumbaugh et al., 2006).

The observation that estradiol-induced signaling in the postsynaptic neuron does not involve direct actions of the estrogen receptor highlights an emerging principle in the organizational action of gonadal steroids on the developing brain, the role of cell-to-cell communication. Advances in the mechanism of sexual differentiation of the Drosophila brain highlight the importance of a single gene, fruitless (fru) (Manoli et al., 2005) and further demonstrate that fru acts in a cell autonomous manner to selectively change the morphology of individual neurons that express the protein (Kimura et al., 2005). One might predict, given the restricted distribution and expression of steroid receptors, a similar potential exists in the mammalian brain. Both the current results and our previous findings establish this is not the case. In the preoptic area, another brain region subject to estradiol-mediated organization of synaptic patterning, the initiating event is increased production of prostaglandin E2 (PGE2) following up regulation of the enzyme COX-2 (Amateau and McCarthy, 2004). Drawing on observations that PGE2 induces glutamate release from astrocytes (Bezzi et al., 1998), a working model proposes that in the POA the prostaglandin is released from the neuron and acts upon neighboring astrocytes to induce glutamate release, which in turn acts back on neurons to activate AMPA receptors and induce the formation of dendritic spines. Therefore, in this brain region, neuronal-astrocytic-neuronal communication is essential. Similarly, neurons in the arcuate nucleus of the hypothalamus undergo estradiol-mediated sexual differentiation that begins in neurons with an increase in GABA synthesis via up regulation of glutamic acid decarboxylase (GAD) (Mong et al., 2002). GABA is released from the neurons, presumably non-synaptically, and activates GABAA receptors on neighboring astrocytes and induces growth and branching of glial processes, i.e. stellation. Through mechanisms that remain poorly understood, the differentiated astrocyte communicates back to the neurons and suppresses the formation of new dendritic spines. Thus, in three circumstances in the mammalian brain in which the cellular mechanisms establishing sex differences in synaptic patterning have been well characterized, there is a defined role for cell-to-cell communication (McCarthy, 2008). The consequence of this mode of differentiation is the potential for steroid-mediated differentiation of neuronal morphology to extend beyond those cells that contain steroid receptors and to coordinate the organization of a more extensive region of the neuropil. As a result, the optimal neural circuitry for integrating sensory and physiological stimuli to maximize reproductive fitness can be achieved.

EXPERIMENTAL PROCEDURES

Animals

Female Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) maintained on a reverse 12 hr light/dark cycle and provided ad libitum food and water were mated in our animal facility and pregnancy confirmed by presence of sperm in a vaginal smear. Pregnant females were isolated and allowed to deliver normally. Cages were checked regularly for presence of pups to determine the time and day of birth [postnatal day 0 (PN0)].

Drugs

All drugs were purchased from Sigma unless otherwise noted. The steroid, 17β-estradiol (250 μg), was dissolved in ethyl oleate. NBQX disodium salt, was dissolved (2.5 μg/0.05 ml) in 0.9% saline. MK801, was dissolved (10 μg/0.05 ml) in 0.9% saline. N-methyl-D-aspartate was dissolved (10 μg/0.05 ml) in 0.9% saline. Biocytin was obtained from Molecular Probes. PD98059, (Calbiochem) was dissolved (100 ng/μl) in 2% DMSO for ICV injections.

Treatment of pups

Estradiol and vehicle were injected subcutaneously (s.c.). PD98059, was infused intracerebroventricularly (ICV) 30 minutes prior to treatment with estradiol or its vehicle. ICV infusions were performed by penetrating the skin and skull with a beveled 23 gauge 1 μl Hamilton syringe stereotaxically lowered to a predetermined depth of 2 mm before infusion of 1 μl over a 60 second period. NBQX, MK801, NMDA, and saline injections were given subcutaneously immediately before estradiol and again four hours after estradiol injection. Exactly 6 hr after treatment, animals were euthanized and the MBH isolated (Fig 1b).

Golgi-Cox impregnation and biocytin analysis

PN0 rats were separated and treated according to the following groups: 1) males + vehicle, 2) females + vehicle, 3) females + 250 μg 17β-estradiol and 4) females + 10 μg NMDA. Six hours after treatment, brains were collected and processed for Golgi impregnation as previously described (Mong et al., 1999; Todd et al., 2007). After processing of both Golgi and biocytin-filled neurons, 5 neurons from each were analyzed for the number of dendritic spines (> 5μm) on each primary dendrite and the length of the primary dendrite (including all branch lengths extending from that dendrite). Data were analyzed with one-way ANOVA, α < 0.05 and Tukey's post-hoc when appropriate.

Western immunoblot

Brain tissue from treated animals and hypothalamic cultures were homogenized in lysis buffer and prepared as described previously (Amateau and McCarthy, 2002a; Todd et al., 2007) and details provided in Supplementary Methods

Whole-cell patch-clamp recordings. Hypothalamic brain slices preparation

For evoked excitatory postsynaptic currents (eEPSC), female pups were treated on PN2 with estradiol (250 μg/0.1 ml ethyl oleate) or vehicle and collected 6 hr later. For miniature excitatory postsynaptic currents (mEPSC), female rat pups were treated with estradiol (100 μg/0.1 ml) or vehicle once a day each day from PN0−2, and collected on PN4−5. Coronal hypothalamic slices (400 μm) containing the VMN region (Fig 3b) were prepared using a Vibratome (Vibratome series 1000, St. Louis, MO) in ice-cold sucrose solution, where NaCl in the artificial cerebral spinal fluid (ACSF) was replaced by an isosmotic concentration of sucrose. Slices were then incubated at 34°C for 20 min, and then allowed to recover for at least 1 hr at RT before experimentation. For evoked EPSCs, vehicle (DMSO 0.01%) or estradiol (10 nM) were included to the ACSF solution during slices preparation and recordings in vehicle or estradiol pretreated animals, respectively. The osmolarity of all solutions used was 305−315 mOsm. Details regarding recording of eEPSC's and mEPSC's can be found in Supplemental Methods.

Electrophysiological data analysis

Cumulative probability distributions of mEPSC amplitude were created either from control or treated cells. Evoked EPSC amplitude was computed from an average of 10 consecutive responses. The amplitude of NMDA receptor-mediated currents, recorded with the cell voltage-clamped at +40 mV, were collected at 60 ms following the stimulation, a time at which AMPA receptor-mediated currents had completely decayed. The ratios of AMPA and NMDA amplitudes were calculated in consecutive time periods with unchanged stimulation parameters. The paired-pulse ratio (PPR) was calculated as the average amplitude of the second of two EPSCs elicited with extracellular stimuli separated by 50 ms, divided by the average amplitude of the first EPSC in the pair. For these data, 10 individual trials were analyzed and the PPR was computed from the averaged trace. Data were expressed as mean ± SEM, and p values were derived from Student's unpaired t-test, with significance levels assessed at p < 0.05, unless otherwise noted.

Hypothalamic cultures

Timed pregnant Sprague-Dawley female rats purchased from Charles River Laboratories (Wilmington, MA, USA) were killed on gestational day 18. The hypothalami were dissected from the brains of approximately 8−9 fetal rats and cultured as described in (Perrot-Sinal et al., 2001). Cells were plated onto poly-L-lysine coated glass coverslips at a density of 250,000 cells/plate with plating medium for western blot experiments and 150,000 cells/plate for imaging experiments (FM and calcium) in 2 ml of SCM. Plates were maintained in an incubator at 37° C and 5 % CO2 for 5 days in vitro before use. (DIV1= day of plating) Culture medium was changed one time on DIV3.

Treatment of cultured neurons

For experiments involving FM4−64 imaging, cultures were treated for 3 or 6 hours with 10 nM β-estradiol or veh, prior to imaging on DIV 5. Pre-treatment with antagonists such as ICI 182,780 (Tocris 1 μM in DMSO), PD98059 (10 μM in DMSO), LY294002 (10 μM in DMSO), or cycloheximide (30 μM in ethanol), occurred 30 minutes prior to estradiol or DMSO treatment. α-Latrotoxin (Calbiochem) was administered in saline at 3 pM in combination or separately from estradiol.

FM4−64 imaging and analysis

Hypothalamic neurons used for FM4−64 imaging were plated on gridded coverslips (Bellco Biotechnology),rinsed in an equilibrating buffer for 15 min before being loaded with 2 μM FM4−64 (SynaptoRed) using a loading buffer for 10 min. Immediately thereafter, neurons were washed in a rinsing buffer (see supplemental methods) for 10 min. Images were captured (red 600−700 nm emission filter) every 3 seconds to minimize photobleaching. After approximately 30 seconds of establishing the baseline fluorescence, the neurons were rinsed for 60 seconds with an unloading buffer (see supplemental methods) containing 50 mM KCl or stimulated at 1 Hz with an extracellular electrode placed in the bath. After ∼2 min of image capture during destaining, unloading of the terminals continued for another 5 min to obtain a picture of the completely destained puncta. This image was considered to represent non-specific staining and was subtracted from all images prior to analysis. Images were analyzed using SimplePCI imaging software (Hamamatsu Inc.). The destaining rate was determined from the change in fluorescence emission over time as described in (Brager et al., 2003; Pyle et al., 1999; Ryan et al., 1996). The mean total fluorescence lost for all boutons on one coverslip was averaged, and this value was then averaged with other coverslips treated identically (n = one coverslip, 3−4 separate culture runs per experiment). The mean total fluorescence lost was compared across treatment groups using a one-way ANOVA. Criterion for significance levels was α<0.05. Neurons analyzed for the rate of neurotransmitter release were also analyzed for the number of loaded boutons and the area of each bouton.

Immunocytochemistry for vGLUT2

Immediately after imaging, coverslips with adhered cells were fixed and prepared for immunocytochemical detection with anti-vesicular glutamate transporter 2 (vGLUT2; Sigma, 1:1,000) then developed as described previously (Speert et al., 2007).

Supplementary Material

Supplementary

Article information

Neuron. Author manuscript; available in PMC 2008 Oct 20.
Published in final edited form as:
PMCID: PMC2570057
NIHMSID: NIHMS67050
1 Program in Neuroscience, University of Maryland, Baltimore Baltimore MD 212101
2 Department of Physiology, University of Maryland, Baltimore Baltimore MD 212101
3 Department of Psychiatry, University of Maryland, Baltimore Baltimore MD 212101
* corresponding author: Jaclyn M. Schwarz University of Maryland, Baltimore 655 W. Baltimore St., 5−014 Baltimore, MD 21201 Email: ude.dnalyramu@500whcsj

References

  • Abraham IM, Herbison AE. Major sex differences in non-genomic estrogen actions on intracellular signaling in mouse brain in vivo. Neuroscience. 2005;131:945–951. [PubMed]
  • Amateau SK, McCarthy MM. A novel mechanism of dendritic spine plasticity involving estradiol induction of prostaglandin-E2. J Neurosci. 2002a;22:8586–8596. [PubMed]
  • Amateau SK, McCarthy MM. Sexual differentiation of astrocyte morphology in the developing rat preoptic area. J Neuroendocrinol. 2002b;14:904–910. [PubMed]
  • Amateau SK, McCarthy MM. Induction of PGE2 by estradiol mediates developmental masculinization of sex behavior. Nat Neurosci. 2004;7:643–650. [PubMed]
  • Aronica SM, Kraus WL, Katzenellenbogen BS. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A. 1994;91:8517–8521. [PMC free article] [PubMed]
  • Balthazart J, Ball GF. Is brain estradiol a hormone or a neurotransmitter? Trends Neurosci. 2006;29:241–249. [PubMed]
  • Beato M. Gene regulation by steroid hormones. Cell. 1989;56:335–344. [PubMed]
  • Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 1998;391:281–285. [PubMed]
  • Brager DH, Luther PW, Erdelyi F, Szabo G, Alger BE. Regulation of exocytosis from single visualized GABAergic boutons in hippocampal slices. J Neurosci. 2003;23:10475–10486. [PubMed]
  • Calizo LH, Flanagan-Cato LM. Estrogen selectively regulates spine density within the dendritic arbor of rat ventromedial hypothalamic neurons. J Neurosci. 2000;20:1589–1596. [PubMed]
  • Capogna M, Gähwiler BH, Thompson SM. Calcium-independent actions of alpha-latrotoxin on spontaneous and evoked synaptic transmission in the hippocampus. J Neurophysiol. 1996;76:3149–3158. [PubMed]
  • Carrer HF, Aoki A. Ultrastructural changes in the hypothalamic ventromedial nucleus of ovariectomized rats after estrogen treatment. Brain Res. 1982;240:221–233. [PubMed]
  • Cousin MA, Malladi CS, Tan TC, Raymond CR, Smillie KJ, Robinson PJ. Synapsin I-associated phosphatidylinositol 3-kinase mediates synaptic vesicle delivery to the readily releasable pool. J Biol Chem. 2003;278:29065–29071. [PubMed]
  • Cremona O, De Camilli P. Phosphoinositides in membrane traffic at the synapse. J Cell Sci. 2001;114:1041–1052. [PubMed]
  • De Vries GJ, Simerly RB. Anatomy, Development, and Function of Sexually Dimorphic Neural Circuits in the Mammalian Brain. Hormones, Brain, and Behavior. 2002;5:137–192.
  • Desai NS, Cudmore RH, Nelson SB, Turrigiano GG. Critical periods for experience-dependent synaptic scaling in visual cortex. Nat Neurosci. 2002;5:783–789. [PubMed]
  • Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443:651–657. [PubMed]
  • Gong LW, Di Paolo G, Diaz E, Cestra G, Diaz ME, Lindau M, De Camilli P, Toomre D. Phosphatidylinositol phosphate kinase type I gamma regulates dynamics of large dense-core vesicle fusion. Proc Natl Acad Sci U S A. 2005;102:5204–5209. [PMC free article] [PubMed]
  • Hanson MG, Landmesser LT. Normal patterns of spontaneous activity are required for correct motor axon guidance and the expression of specific guidance molecules. Neuron. 2004;43:687–701. [PubMed]
  • Haverkamp LJ, Oppenheim RW. Behavioral development in the absence of neural activity: effects of chronic immobilization on amphibian embryos. J Neurosci. 1986;6:1332–1337. [PubMed]
  • Holt M, Cooke A, Wu MM, Lagnado L. Bulk membrane retrieval in the synaptic terminal of retinal bipolar cells. J Neurosci. 2003;23:1329–1339. [PubMed]
  • Huang F, Chotiner JK, Steward O. Actin polymerization and ERK phosphorylation are required for Arc/Arg3.1 mRNA targeting to activated synaptic sites on dendrites. J Neurosci. 2007;27:9054–9067. [PubMed]
  • Iyengar S, Bottjer SW. The role of auditory experience in the formation of neural circuits underlying vocal learning in zebra finches. J Neurosci. 2002;22:946–958. [PubMed]
  • Kim MJ, Dunah AW, Wang YT, Sheng M. Differential roles of NR2A-and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron. 2005;46:745–760. [PubMed]
  • Kimura K, Ote M, Tazawa T, Yamamoto D. Fruitless specifies sexually dimorphic neural circuitry in the Drosophila brain. Nature. 2005;438:229–233. [PubMed]
  • Lee SJ, Campomanes CR, Sikat PT, Greenfield AT, Allen PB, McEwen BS. Estrogen induces phosphorylation of cyclic AMP response element binding (pCREB) in primary hippocampal cells in a time-dependent manner. Neuroscience. 2004;124:549–560. [PubMed]
  • Lin CH, Yeh SH, Lin CH, Lu KT, Leu TH, Chang WC, Gean PW. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron. 2001;31:841–851. [PubMed]
  • Manoli DS, Foss M, Villella A, Taylor BJ, Hall JC, Baker BS. Male-specific fruitless specifies the neural substrates of Drosophila courtship behaviour. Nature. 2005;436:395–400. [PubMed]
  • Matsumoto A, Arai Y. Sexual dimorphism in ‘wiring pattern’ in the hypothalamic arcuate nucleus and its modification by neonatal hormonal environment. Brain Res. 1980;190:238–242. [PubMed]
  • Matsumoto A, Arai Y. Development of sexual dimorphism in synaptic organization in the ventromedial nucleus of the hypothalamus in rats. Neurosci Lett. 1986a;68:165–168. [PubMed]
  • Matsumoto A, Arai Y. Male-female difference in synaptic organization of the ventromedial nucleus of the hypothalamus in the rat. Neuroendocrinology. 1986b;42:232–236. [PubMed]
  • McCarthy MM. Estradiol and the developing brain. Physiological Reviews. 2008 [PMC free article] [PubMed]
  • McCarthy MM, Schlenker EH, Pfaff DW. Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain. Endocrinology. 1993;133:433–439. [PubMed]
  • McEwen BS, Lieberburg I, Maclusky N, Plapinger L. Do estrogen receptors play a role in the sexual differentiation of the rat brain? J Steroid Biochem. 1977;8:593–598. [PubMed]
  • Mong JA, Glaser E, McCarthy MM. Gonadal steroids promote glial differentiation and alter neuronal morphology in the developing hypothalamus in a regionally specific manner. J Neurosci. 1999;19:1464–1472. [PubMed]
  • Mong JA, Nunez JL, McCarthy MM. GABA mediates steroid-induced astrocyte differentiation in the neonatal rat hypothalamus. J Neuroendocrinol. 2002;14:45–55. [PubMed]
  • Mori Y, Higuchi M, Masuyama N, Gotoh Y. Adenosine A2A receptor facilitates calcium-dependent protein secretion through the activation of protein kinase A and phosphatidylinositol-3 kinase in PC12 cells. Cell Struct Funct. 2004;29:101–110. [PubMed]
  • Murphy DD, Segal M. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci. 1996;16:4059–4068. [PubMed]
  • Naftolin F, Ryan KJ, Petro Z. Aromatization of androstenedione by the diencephalon. J Clin Endocrinol Metab. 1971;33:368–370. [PubMed]
  • O'Malley D, Harvey J. MAPK-dependent actin cytoskeletal reorganization underlies BK channel activation by insulin. Eur J Neurosci. 2007;25:673–682. [PubMed]
  • Opazo P, Watabe AM, Grant SG, O'Dell TJ. Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J Neurosci. 2003;23:3679–3688. [PubMed]
  • Perrot-Sinal TS, Davis AM, Gregerson KA, Kao JP, McCarthy MM. Estradiol enhances excitatory gamma-aminobutyric [corrected] acid-mediated calcium signaling in neonatal hypothalamic neurons. Endocrinology. 2001;142:2238–2243. [PubMed]
  • Pozzo Miller LD, Aoki A. Stereological analysis of the hypothalamic ventromedial nucleus. II. Hormone-induced changes in the synaptogenic pattern. Brain Res Dev Brain Res. 1991;61:189–196. [PubMed]
  • Pyle JL, Kavalali ET, Choi S, Tsien RW. Visualization of synaptic activity in hippocampal slices with FM1−43 enabled by fluorescence quenching. Neuron. 1999;24:803–808. [PubMed]
  • Quadros PS, Pfau JL, Goldstein AY, De Vries GJ, Wagner CK. Sex differences in progesterone receptor expression: a potential mechanism for estradiol-mediated sexual differentiation. Endocrinology. 2002;143:3727–3739. [PubMed]
  • Rizzoli SO, Betz WJ. Effects of 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one on synaptic vesicle cycling at the frog neuromuscular junction. J Neurosci. 2002;22:10680–10689. [PubMed]
  • Rumbaugh G, Adams JP, Kim JH, Huganir RL. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc Natl Acad Sci U S A. 2006;103:4344–4351. [PMC free article] [PubMed]
  • Ryan TA, Ziv NE, Smith SJ. Potentiation of evoked vesicle turnover at individually resolved synaptic boutons. Neuron. 1996;17:125–134. [PubMed]
  • Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol. 1997;388:507–525. [PubMed]
  • Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol. 1990;294:76–95. [PubMed]
  • Singh M, Setalo G, Jr., Guan X, Warren M, Toran-Allerand CD. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci. 1999;19:1179–1188. [PubMed]
  • Speert DB, Konkle AT, Zup SL, Schwarz JM, Shiroor C, Taylor ME, McCarthy MM. Focal adhesion kinase and paxillin: novel regulators of brain sexual differentiation? Endocrinology. 2007;148:3391–3401. [PubMed]
  • Todd BJ, Schwarz JM, McCarthy MM. Prostaglandin-E2: a point of divergence in estradiol-mediated sexual differentiation. Horm Behav. 2005;48:512–521. [PubMed]
  • Todd BJ, Schwarz JM, Mong JA, McCarthy MM. Glutamate AMPA/Kainate receptors, not GABAA receptprs, mediate estradiol-induced sex differences in the hypothalamus. Developmental Neurobiology. 2007;67:304–315. [PubMed]
  • Toker A, Cantley LC. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997;387:673–676. [PubMed]
  • Uht RM, Anderson CM, Webb P, Kushner PJ. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology. 1997;138:2900–2908. [PubMed]
  • Vasudevan N, Pfaff DW. Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev. 2007;28:1–19. [PubMed]
  • Wong RO. Retinal waves and visual system development. Annu Rev Neurosci. 1999;22:29–47. [PubMed]
  • Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci. 1992;12:2549–2554. [PubMed]
  • Yokomaku D, Numakawa T, Numakawa Y, Suzuki S, Matsumoto T, Adachi N, Nishio C, Taguchi T, Hatanaka H. Estrogen enhances depolarization-induced glutamate release through activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase in cultured hippocampal neurons. Mol Endocrinol. 2003;17:831–844. [PubMed]
  • Zhang LI, Poo MM. Electrical activity and development of neural circuits. Nat Neurosci. 2001;4(Suppl):1207–1214. [PubMed]
  • Zhou Y, Watters JJ, Dorsa DM. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology. 1996;137:2163–2166. [PubMed]
  • Znamensky V, Akama KT, McEwen BS, Milner TA. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci. 2003;23:2340–2347. [PubMed]
  • Zucker RS, Regehr WG. Short-term synaptic plasticity. Annu Rev Physiol. 2002;64:355–405. [PubMed]

Figure 1

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0001.jpg
Estradiol and NMDA induce dendritic spines and spinophilin in the MBH

(a) Golgi-Cox impregnated neurons were morphologically assessed (representative photomicrographs in upper left hand panel, scale bar = 10 uM).

In upper right panel, males had significantly more dendritic spines per dendrite and dendrites were significantly longer than in females on the day of birth (ANOVA F3,19= 8.8;

* p < 0.005 compared to all other groups).

(b) A coronal schematic of the rodent brain is shown in the middle left panel (Paxinos and Watson, 2004). The rectangle indicates the outline of the medial basal hypothalamus (MBH) dissection.

In middle right panel, western blot for spinophilin indicates males had higher levels than females on the day of birth, and treatment of females with estradiol (E2) increased spinophilin to levels seen in males within 6 hr (ANOVA F3,19=3.47; *p<0.05 compared to all other groups; n = 5−6 / group).

(c) MBH tissue was collected at 6 or 48 hr post estradiol E2. Spinophilin was significantly elevated at both time points compared to controls (ANOVA F3,20= 4.09; *p < 0.05; n = 5−6 / group). There was no difference in spinophilin levels between vehicle-treated animals at 6 hr versus 48 hr (p=0.90), and these were collapsed into one group.

Figure 2

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0002.jpg
Glutamate receptor activation is necessary and sufficient for estradiol-induced increases in dendritic spines

(a) Left upper panel: Estradiol treatment induced a 3-fold increase in spinophilin and pretreatment with the AMPA receptor antagonist NBQX, completely blocked the increase (ANOVA F3,17=7.04; *p<0.05, n = 5−6 group compared to all other groups).

Right upper panel: In a separate experiment, estradiol again significantly increased spinophilin and pre-treatment with the NMDA receptor antagonist, MK801, also completely prevented the increase (ANOVA F3,13= 13.29; *p < 0.05 compared to all other groups, n = 5−6 / group).

(b) Treatment of females on the day of birth with either estradiol or NMDA to directly activate NMDA receptors significantly increased spinophilin levels within 6 hours (ANOVA F2,20=7.70; *p< 0.05 compared to vehicle; Veh n=9, E2 n=9, NMDA n=5).

Figure 3

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0003.jpg
Estradiol has no effect on mEPSC amplitude

(a) Left upper panel: Representative traces of mEPSCs recorded from neurons in the VMN treated with or without estradiol for 2 days beginning at birth and the corresponding cumulative probability plot (n.s., KS test).

Right upper panel: Estradiol treatment had no effect on the median amplitude (pA) (t16=−0.87; p = 0.238), frequency (Hz) (t16=−1.22; p = 0.396), or the decay time (ms) (t16=−0.57; p = 0.572) of mEPSCs recorded from these neurons (n=8−10 neurons).

(b) Representative photomicrograph of an MBH slice used for recording mEPSCs from ventrolateral VMN (vlVMN). Arrow indicates a neuron filled with biocytin after recording. ARC = arcuate nucleus. III = the third ventricle. Images immediately to the right show representative neurons recorded from and loaded with biocytin.

In lower panels: Morphological analysis of biocytin-filled neurons in slices from females treated with estradiol for 48 hrs at birth revealed increased dendritic spines along the primary dendrite (t7=2.67; *p < 0.05 compared to vehicle), and increased total dendrite length (t8=2.41; *p<0.05 compared to vehicle; Veh n = 4 and estradiol n = 6 neurons).

Figure 4

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0004.jpg
Estradiol enhances glutamate release from hypothalamic neurons

(a) Left panel: Representative EPSCs evoked from neurons treated with or without estradiol. Estradiol had no effect on the ratio of AMPA (recorded at a holding potential of −80 mV) to NMDA currents (recorded at +40 mV)(t12=−0.24; p=0.81; Veh n=7 and E2 n=7).

(b) Right panel: In the same neurons, EPSCs elicited with pairs of stimuli (interstimulus interval = 50 ms, holding potential = −80 mV) indicated estradiol pretreatment significantly decreased the paired-pulse ratio (amplitude of second EPSC/amplitude of first EPSC), consistent with an increase in the probability of glutamate release after estradiol treatment (t21=−2.72; *p<0.05 compared to vehicle).

Figure 5

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0005.jpg
Estradiol enhances glutamate release within 3 hours

(a) Left upper panel: Photomicrograph of cultured hypothalamic neurons viewed under low magnification immediately prior to fluorescent FM4−64 imaging. The rectangle represents the area of the neurite from the same cultured hypothalamic neuron viewed at higher magnification prior to FM4−64 imaging (DIC). Fluorescence image of the same neurite showing the punctate loading of FM4−64 dye at terminals. Immediately to the right, representative photomicrograph of the gridded coverslip (Bellco) with an etched numbered grid (square = 0.6 mm × 0.6 mm) used to identify neurons and terminals during imaging and after fixation for VGLUT2 immunocytochemistry. Representative pictures of both fluorescent FM4−64 labeling and the same boutons stained with VGLUT2 indicate that the analyzed boutons were glutamatergic (Scale bars = 10 μm).

(b) Left middle panel: Plots show the total mean ± SEM of fluorescence lost at each time point upon depolarization. Following depolarization with either 1 Hz electrical stimulation or 50 mM KCl, neurons treated with estradiol (E2) exhibited an increased rate of destaining.

Right middle panel: Normalized fluorescence intensity values expressed as a % change from baseline. Treatment with E2 significantly increased % destaining after 30 sec of depolarization induced by either 50 mM KCl or 1 Hz stimulation (F3,16= 3.94; *p<0.05 compared to vehicle; Veh (1 Hz) n=3, Veh (50 mM) n=6, E2 (1 Hz) n=3, E2 (50 mM) n=8 coverslips).

(c) Left lower panel: Plots show the total mean ± SEM of fluorescence lost at each time point upon depolarization with 50 mM KCl. Treatment with E2 increased the rate of FM4−64 destaining in response to a depolarizing stimulus and pretreatment of hypothalamic neurons with ICI 182,780 (ICI) completely blocked the estradiol-enhanced release of neurotransmitter (ANOVA F3,7=6.29; *p<0.05 compared to all other groups; n=3 coverslips per group). Inset: In a separate analysis, neurons treated with E2 for less than 2 hr show enhanced neurotransmitter release compared to vehicle-treated neurons (Veh) (t6=2.37, *p ≤ 0.05 compared to vehicle).

Figure 6

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0006.jpg
Estradiol enhances neurotransmitter release via non-genomic activation of PI3 kinase

(a) Left upper panel: Plots show the total mean ± SEM of fluorescence lost at each time point upon depolarization with 50 mM KCl. Treatment with estradiol (E2) increased the rate of FM-46 destaining in response to a depolarizing stimulus and pretreatment of neurons with cycloheximide (CHX) had no effect on this increase.

Left lower panel: Normalized fluorescence intensity values are expressed as a percent change from baseline. Treatment with E2 for 3 hr again increased the rate of FM4−64 destaining in response to a depolarizing stimulus (ANOVA F3,24= 3.66; *p < 0.05 compared to vehicle and CHX) and pretreatment with CHX, a translation inhibitor, had no effect on E2 enhanced or baseline neurotransmitter release (Veh n = 8, E2 n = 8, CHX + E2 n = 8, CHX n = 4 coverslips).

Right lower panel: Western blot analysis for spinophilin protein indicates 30 μM cycloheximide is a sufficient dose to block the synthesis of new proteins, including the E2-induced increase in spinophilin seen 6 hr after treatment. (ANOVA F3,18= 3.17; *p < 0.05 compared to all other groups). This further confirms that the E2-induced increase in spinophilin is downstream of non-genomic enhancement of glutamate release (Veh n = 6, E2 n = 6, CHX + E2 n = 8, CHX n = 4 coverslips).

(b) Left upper panel: Cultured hypothalamic neurons were treated with Veh, E2 and/or LY294002 (LY), the PI3 kinase inhibitor, for 3 hr prior to FM4−64 imaging. Plots show the total mean fluorescence lost at each time point upon depolarization with 50 mM KCl. Right upper panel: Normalized fluorescence intensity values are expressed as a percent change from baseline. Treatment with E2 for 3 hr increased the rate of FM4−64 destaining in response to a depolarizing stimulus (F3,22= 3.91; * p < 0.05 compared to all other groups) and pretreatment with LY293002 blocked this increase (Veh n = 7, E2 n = 7, LY + E2 n = 8, LY n = 4 coverslips).

Left lower panel: E2 significantly activates PI3 kinase as seen by the phosphorylation of its substrate, Akt (serine473), within 1 hr and activation is maintained for up to 6 hrafter treatment. (ANOVA F5,21=3.89; *p<0.05 compared to vehicle, 10min. and 30 min (n=4−5 coverslips for each time point). Right lower panel: Treatment of cultured hypothalamic neurons with LY294002 also completely blocked the E2-induced increase in spinophilin protein as seen by western blot analysis (ANOVA F3,15= 4.39; * p < 0.05 compared to all other groups n=4−5 coverslips / group).

Figure 7

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0007.jpg
Estradiol activates MAP kinase downstream of glutamate receptor activation to induce dendritic spine formation

(a) Left upper panel: Cultured hypothalamic neurons were treated with vehicle (Veh), estradiol (E2) and/or PD98059 (PD), a potent MEK 1/2 inhibitor, for 3 hr prior to FM4−64 imaging. Plots show the total mean ± SEM of fluorescence lost at each time point upon depolarization with 50 mM KCl.

Right upper panel: Normalized fluorescence intensity values are expressed as % change from baseline. Treatment with E2 for 3 hr increased the rate of FM4−64 destaining in response to a depolarizing stimulus and pretreatment with PD98059 had no effect on E2-enhanced destaining (ANOVA F3,22= 6.67; *p < 0.05 compared to vehicle and PD; Veh n = 7, E2 n = 7, PD + E2 n = 8, PD n = 4 coverslips).

Left lower panel: E2 treatment significantly increased activation of MAP kinase within 3 hr, as seen by the phosphorylation of its substrate, phospho ERK 1/2 (ANOVA F2,12=6.60; *p<0.05 compared to other groups). E2 had no effect on phospho ERK 1/2 at 1 hr (Veh n = 6, E2 1 hr n = 5, E2 3 hr n = 4 animals).

(b) Left upper panel: In the same animals from Fig 2a, E2 treatment for 6 hr induced a 2-fold increase in the activation of MAP kinase, as seen by phosphorylation of ERK 1/2 and pretreatment with the AMPA receptor antagonist NBQX, completely blocked the activation of MAP kinase (ANOVA F3,17=2.96; *p<0.05 compared to all other groups; n = 5−6 animals / group).

Right upper panel: In the same animals from Fig 2a, E2 treatment significantly increased phosphorylation of ERK 1/2, and pretreatment with the NMDA receptor antagonist, MK801, completely blocked the E2-induced activation of MAP kinase (F3,17= 4.79; *p < 0.05 compared to all other groups; n = 5−6 animals / group).

(c) Left lower panel: Pretreatment of females with PD98059 completely blocked E2-induced activation of MAP kinase as seen by phosphorylation of ERK 1/2. (ANOVA F3,16=7.91; *p<0.05 compared to all other groups; n = 5 animals / group).

Right lower panel: In the same tissue, E2 treatment significantly increased spinophilin levels, and pre-treatment with PD98059 blocked the E2-induced increase in spinophilin in the MBH (ANOVA F3,16= 12.8; *p<0.05 compared to all other groups; n= 5 animals / group).

Fig 8

An external file that holds a picture, illustration, etc.
Object name is nihms-67050-f0008.jpg
Evoked neurotransmitter release increases spinophilin levels in hypothalamic neurons

(a) Upper panel: Treatment of cultured hypothalamic neurons with estradiol significantly increases levels of spinophilin protein and pretreatment with the estrogen receptor (ER) antagonist, ICI 182,780, prevents this increase. Treatment of neurons with the secretagogue, α-latrotoxin, to evoke neurotransmitter release recovers the effect of blocking ER and increases spinophilin to that seen with estradiol treatment alone (ANOVA F4,20= 9.86; p = 0.001 compared to vehicle). ICI alone has no effect on spinophilin (p = 0.439, data not shown; n=5−6 coverslips / group). (b) Lower panel: In a separate experiment, treatment of cultured hypothalamic neurons with α-latrotoxin, evoking neurotransmitter release, also increases spinophilin to the levels seen with estradiol treatment (ANOVA, F3,26= 3.65; p < 0.05 compared to vehicle). Combined estradiol and α-latrotoxin treatment does not increase spinophilin levels to more than that seen with either drug alone (p = 0.22; n = 6−8 / group).